The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, Y, R
1
R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, and R
9
are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.
[EN] NOVEL PHENYL IMIDAZOLES AND PHENYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS<br/>[FR] NOUVEAUX PHÉNYL IMIDAZOLES ET PHÉNYL TRIAZOLES EN TANT QUE MODULATEURS DE LA GAMMA SÉCRÉTASE
申请人:PFIZER
公开号:WO2010100606A1
公开(公告)日:2010-09-10
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease
申请人:Burkamp Frank
公开号:US20100016308A1
公开(公告)日:2010-01-21
Tetrahydroindole derivatives of formula (I): are disclosed. These compounds modulate the activity of gamma-secretase and hence find use in treatment or prevention of Alzheimer's disease.
Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
申请人:Allen Martin Patrick
公开号:US20120053165A1
公开(公告)日:2012-03-01
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.